DR. DANIEL ISRAEL SHRAGER M.D. NPI 1396784120

NPI Details

DR. Daniel Israel Shrager, M.D. is a dermatology in Sellersville, PA with 31 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. DR. Daniel Israel Shrager, M.D. NPI is 1396784120. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

670 LAWN AVE
SUITE 1A
SELLERSVILLE, PA
ZIP 18960-571
Phone: (215) 257-0196
Fax: (215) 257-1211

The NPI 1396784120 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tildrakizumab, 1 mg (HCPCS:J3245)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Puraply xt, per square centimeter (HCPCS:Q4197)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• High dose rate electronic brachytherapy, external (HCPCS:0394T)
• Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS:77280)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Incision biopsy, first skin growth (HCPCS:11106)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Biopsy of ear (HCPCS:69100)
• Repair of wound of scalp, arms, or legs by transferring skin, 10.0 sq cm or less (HCPCS:14020)
• Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less (HCPCS:14040)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11402)
• Punch biopsy, first skin growth (HCPCS:11104)
• Incision biopsy, each additional skin growth (HCPCS:11107)
• Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less (HCPCS:15271)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11403)
• Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less (HCPCS:15275)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less (HCPCS:12031)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Complicated repair of wound of trunk, 2.6-7.5 cm (HCPCS:13101)
• Biopsy of eyelid (HCPCS:67810)
• Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm (HCPCS:13120)
• Complicated repair of wound of trunk, 1.1-2.5 cm (HCPCS:13100)
• Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm (HCPCS:13121)
• Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm (HCPCS:13131)
• Repair of wound of trunk by transferring skin, 10.0 sq cm or less (HCPCS:14000)
• Biopsy of lip (HCPCS:40490)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Removal of growth under skin of neck or front of chest, less than 3.0 cm (HCPCS:21555)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Removal of growth under skin of back or lower sides, less than 3.0 cm (HCPCS:21930)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm (HCPCS:17283)
• Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm (HCPCS:11604)
• Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:11642)
• Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11603)
• Removal of noncancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:11422)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Punch biopsy, each additional skin growth (HCPCS:11105)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/6/2006 and was last updated on 7/9/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.